Literature DB >> 2991742

Cyclic AMP, nuclear protein kinase and the PY815 cell cycle.

M Goulding, R K Ralph.   

Abstract

A substantial increase in cyclic AMP-dependent protein kinase activity occurred in nuclei of PY815 mastocytoma cells during G1 phase growth arrest by DB cyclic AMP and the increased nuclear protein kinase was accompanied by changes in nuclear protein phosphorylation. However, there was no obligatory association between the rise in nuclear cyclic AMP-dependent protein kinase in G1 phase and growth arrest because nuclear cyclic AMP-dependent protein kinase also increased during G1 phase in cycling PY815 cells synchronized with amethopterin. These observations suggest that maintenance of high cyclic AMP levels during G1 phase may cause growth arrest by activating a cyclic AMP-dependent protein kinase that normally increases in PY815 cell nuclei during G1 phase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991742     DOI: 10.1007/bf00220983

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

1.  Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regression.

Authors:  Y S Cho-Chung; T Clair; J P Zubialde
Journal:  Biochem Biophys Res Commun       Date:  1978-12-14       Impact factor: 3.575

Review 2.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

3.  Regulation of growth of mouse mastocytoma cells.

Authors:  J Davis; R K Ralph
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

Review 4.  Type I cyclic AMP-dependent protein kinase as a positive effector of growth.

Authors:  D H Russell
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

5.  Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom.

Authors:  J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

6.  Cell cycle specific fluctuations of adenosine 3',5' -monophosphate and prostaglandin binding in synchronized mastocytoma P-815 cells.

Authors:  M Negishi; A Ichikawa; N Oshio; K Yatsunami; K Tomita
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

7.  Properties of the cyclic AMP-dependent protein kinases in mouse mastocytoma cells.

Authors:  J Smart; R Ralph
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

8.  Dibutyryl cyclic AMP treatment mimics ovariectomy: new genomic regulation in mammary tumor regression.

Authors:  F L Huang; Y S Cho-Chung
Journal:  Biochem Biophys Res Commun       Date:  1982-07-16       Impact factor: 3.575

9.  Enhanced synthesis and stabilization of Mr 68,000 protein in transformed BALB/c-3T3 cells: candidate for restriction point control of cell growth.

Authors:  R G Croy; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Changes in cyclic AMP-dependent protein kinases during inhibition of mastocytoma cell growth by dibutyryl cyclic AMP.

Authors:  J Evans; J Smart; P Airey; R Ralph
Journal:  Mol Cell Biochem       Date:  1982-04-02       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.